Showing results (181-190 of 269) with videos related to
Sort By:
Pageof 27
Anatomia, Histologia, Embryologia|October 2, 2009
Histological structure and distribution of carbonic anhydrase isozymes (CA-I, II, III and VI) in major salivary glands in koalasT Mizuno, A McKinnon, N Ichihara, et al.Journal of Chemical Information and Computer Sciences|November 25, 2003
Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoformsMichael J Sorich, John O Miners, Ross A McKinnon, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 2024
Activation of Cryptic Donor Splice Sites within the UDP-Glucuronosyltransferase (UGT)1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins with Truncated Aglycone-Binding DomainsDong Gui Hu, Shashikanth Marri, Julie-Ann Hulin, et al.Journal of Cancer|April 2, 2020
Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus CapecitabineFang L I Ang, Andrew Rowland, Natansh D Modi, et al.The Journal of Biological Chemistry|February 3, 1995
Interaction with TrkA immobilizes gp75 in the high affinity nerve growth factor receptor complexD E Wolf, C A McKinnon, M C Daou, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2018
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic ReviewRoss A McKinnon, Matthew Cook, Winston Liauw, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2022
Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control TrialsAshley M Hopkins, Sarah Badaoui, Ganessan Kichenadasse, et al.Frontiers in Oncology|August 18, 2022
C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/BevacizumabAhmad Y Abuhelwa, Joaquim Bellmunt, Ganessan Kichenadasse, et al.Journal of Bone and Mineral Metabolism|June 10, 2015
Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female ratsChiaming Fan, Kristen R Georgiou, Ross A McKinnon, et al.British Journal of Cancer|May 20, 2015
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancerA Rowland, M M Dias, M D Wiese, et al.Pageof 27